AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimven-M1 Plus Tablet SR

Prescription Icon
Prescription Required

Marketer

Anvicure Drugs

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimven-M1 Plus Tablet SR

DiaGlyc-Duo SR tablets are antidiabetic medications combining two active ingredients for managing type 2 diabetes in adults. They help regulate blood glucose. DiaGlyc-Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, nerve damage, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood cell count and liver function tests as deemed necessary by your doctor, are recommended.

Primary Ingredients of Glimven-M1 Plus Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimven-M1 Plus Tablet SR

Managing Type 2 diabetes

Major Benefits of Glimven-M1 Plus Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimven-M1 Plus Tablet SR with a meal.

Common Side effects of Glimven-M1 Plus Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimven-M1 Plus Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimven-M1 Plus Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.

How Glimven-M1 Plus Tablet SR works:

Glimven-M1 Plus SR tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Glimven-M1 Plus Tablet SR is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimven-M1 Plus Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before using this drug.

Breast feedingBreast feedingUNSAFE

Extended-release Glimven-M1 Plus tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Exercise caution when administering Glimven-M1 Plus Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Glimven-M1 Plus Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimven-M1 Plus Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. For individuals with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimven-M1 Plus Tablet SR :

Should you forget a Glimven-M1 Plus Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimven-M1 Plus Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimven-M1 Plus Tablet SR

Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any remaining medication after use. Prevent access by children, pets, and others.
Indeed, Glimven-M1 Plus Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare adverse effect is particularly dangerous for individuals with pre-existing kidney impairment, the elderly, or those who consume significant amounts of alcohol. Warning signs of lactic acidosis can encompass muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, and bradycardia. Should these symptoms appear, discontinue Glimven-M1 Plus Tablet SR use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimven-M1 Plus Tablet SR, treat type 2 diabetes mellitus in adults. This medication enhances blood glucose control when coupled with a suitable diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This formulation is unsuitable for type 1 diabetes mellitus.
Glimven-M1 Plus SR tablets may cause common adverse reactions including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimven-M1 Plus Tablet SR use can indeed lead to Vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum annually, is recommended by some studies.
Glimven-M1 Plus Tablet SR can indeed lead to hypoglycemia, characterized by low blood glucose. Symptoms may include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available source of fast-acting sugar, such as glucose tablets, honey, or fruit juice.
Combining Glimven-M1 Plus Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption also raises the probability of lactic acidosis.
Glimven-M1 Plus Tablet SR
105
MRP 128
17% off